What we do
According to the World Health Organization (WHO), approximately 2.2 billion people worldwide have some form of vision impairment or blindness, with conditions ranging from mild to severe.
Ophthalmology CRO Expert
By successfully completing 13 Ophthalmology clinical trials (phases II-IV, including medical devices) in the last five years, we have contributed to improved outcomes for patients with eye-related conditions.
We conducted clinical trials for various eye conditions, including AMD, DME, Dry Eye, Geographic Atrophy, Glaucoma, Uveitis, and Retinitis Pigmentosa. Our team of over 50 experienced staff members successfully collaborated with more than 150 sites.
Let’s continue working together to improve patients’ quality of life through better vision and eye health!
13 Studies conducted
64% of Phase III studies

240+
patients enrolled
Close collaboration with
155 sites
7 different indications
7 studies in Age-related macular degeneration (AMD). List of studies per indication:

Staff experience
55 staff members with Ophthalmology experience
